Everest Group (EG)
NYSEFinancialsInsurance - ReinsuranceSnapshot 2026-07-07
$373.23+0.08%
Close 2026-07-07 · 1-day change
Reading EG? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track EG free→NYSEFinancialsInsurance - ReinsuranceSnapshot 2026-07-07
Reading EG? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track EG free→QuarterlyIQ Insights · EG
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 11 valuation methods, at three horizons. Current price $373.23. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $373 EG trades at 1.0× p/b, below its 2.1× p/b peer median. Our $518 fair value sits well above the price. We hold it with low confidence: our number sits well above the analyst range and the peer anchor overstates how cheap it looks. Analysts target $340–$420. Note: our $518 fair value sits above the entire analyst range ($340–$420). Not investment advice.
$340.00 – $420.00 (median $365.00) · 7 analysts · as of 2026-07-07
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks cheaper than most peers in the same business.
Around its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $365.00 | — | — | Analyst | high |
| ddm gordon | 12M | $160.10 | — | — | TTM | high |
| graham number | 12M | $684.74 | — | — | TTM | high |
| Mgmt guidance | 12M | $251.70 | 16.5 | 15.21 | Mgmt | high |
| Peer P/B | 12M | $806.07 | 2.1 | 384.20 | TTM | high |
| Peer P/E | 12M | $897.58 | 16.5 | 54.24 | TTM | high |
| Peer P/S | 12M | $1466.83 | 3.4 | 434.70 | TTM | high |
| PEG | 12M | $795.48 | 14.7 | 54.24 | TTM | high |
| residual income | 12M | $484.10 | — | — | TTM | high |
| Own P/E history | 12M | $371.35 | 6.8 | 54.24 | TTM | high |
| triangulated | 12M | $924.24 | 16.5 | 55.85 | Triangulated | high |
| Mgmt guidance | 3Y | $313.93 | 16.5 | 18.97 | Mgmt(prov.) | medium |
| Peer P/B | 3Y | $1225.93 | 2.1 | 584.31 | Hist. CAGR(prov.) | medium |
| Mgmt guidance | 5Y | $363.74 | 16.5 | 21.98 | Mgmt(prov.) | medium |
| Peer P/B | 5Y | $1621.29 | 2.1 | 772.76 | Hist. CAGR(prov.) | medium |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.